JPM23: Is GSK’s 15-day accelerated approval withdrawal the new normal? Hear FDA commissioner Califf’s response esagonowsky Wed, 01/11/2023 – 10:34 More: JPM23: Is GSK’s 15-day accelerated approval withdrawal the new normal? Hear FDA commissioner Califf’s response Source: fierce
read moreLilly, Biogen and more gear up for blockbuster launches in 2023: report kdunleavy Wed, 01/11/2023 – 10:19 More: Lilly, Biogen and more gear up for blockbuster launches in 2023: report Source: fierce
read moreCandidate will go through the development programme, which includes safety and tolerability studies More: AlzeCure begins Alzheimer's therapy development phase Source: News
read moreGlobal preclinical programme has the potential for disease modifying therapeutics More: Pheno and UCB reveal neurodegenerative disease programme agreement Source: News
read moreJPM23: Bayer hikes sales targets for Kerendia, Nubeqa to $3B each kdunleavy Tue, 01/10/2023 – 15:42 More: JPM23: Bayer hikes sales targets for Kerendia, Nubeqa to B each Source: fierce
read moreJPM23: J&J stayed in the back seat during Horizon bidding war, CEO says fkansteiner Tue, 01/10/2023 – 12:39 More: JPM23: J&J stayed in the back seat during Horizon bidding war, CEO says Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals